Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Approves "Unprecedented" Risk Management Program For Accutane

Aug 12 2005

• By Andrew Shelton

Related Content

Accutane Risk Management Program Changes Held Up By Celgene Patents

Jul 13 2004

Enhanced Isotretinoin Risk Management Plan To Commence In Mid-2005

Nov 23 2004

Isotretinoin Psychiatric Disorder Warning Strengthened

Aug 12 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window